Drug Development for Stroke

• Development of Small Molecule Drug for Stroke
  • Targeted Stroke Drug Development

    • Stroke Drug Development Targeting Noncoding RNAs
    • Stroke Drug Development Targeting PSD-95
    • Stroke Drug Development Targeting Tau
    • Stroke Drug Development Targeting Heat Shock Protein 70
    • Stroke Drug Development Targeting Notch
    • Stroke Drug Development Targeting Guanosine
    • Stroke Drug Development Targeting Nogo-A
    • Stroke Drug Development Targeting Nrf2
    • Stroke Drug Development Targeting DAPK1
    • Stroke Drug Development Targeting AMPK
    • Stroke Drug Development Targeting Caveolin-1
  • Stroke Drug Development Targeting Cell Death

    • Stroke Drug Development Targeting Ferroptosis
    • Stroke Drug Development Targeting Pyroptosis
    • Stroke Drug Development Targeting Necroptosis
  • Stroke Drug Development Targeting Different Cell Types

    • Stroke Drug Development Targeting Astrocytes
    • Stroke Drug Development Targeting Microglia
  • Stroke Drug Development Targeting Other Components

    • Stroke Drug Development Targeting Mitochondria
    • Stroke Drug Development Targeting Autophagy
    • Stroke Drug Development Targeting Epigenetic Mechanisms
    • Stroke Drug Development Targeting Blood Brain Barrier
    • Stroke Drug Development Targeting Excitotoxicity

      • Stroke Drug Development Targeting NMDAR
      • Stroke Drug Development Targeting The GluN2B Subunit of NMDAR
      • Stroke Drug Development Targeting Glutamate
• Development of Biologics for Stroke
  • Development of Stem Cellular Therapy for Stroke
  • Stroke Drug Development Targeting Gut Microbiota
  • Development of Therapeutic Antibodies for Stroke
  • Development of Exosome-Based Stroke Therapy
  • Development of UCHL1-Based Stroke Therapy

Stroke affects many people worldwide. However, due to the complexity of stroke and the very short treatment window, there are no effective therapies for stroke. Ace Neuroscience has more than a decade of research experience in the stroke field. Based on our extensive research experience and advanced technology platform, we are committed to facilitating progress in stroke drug development and helping you with your stroke drug development research.

Small Molecule for Stroke

Small molecule drugs have many unparalleled advantages, such as low production costs, low transport requirements for ease of transport, the ability to cross cell membranes and act directly on intracellular targets, and better tissue permeability. Therefore, small molecule drugs have an important role to play in stroke therapy. We have more than ten years of research experience in the field of small molecule drug development in stroke and have formed a unique research service system, which can provide you with scientific and comprehensive research services.

• Stroke Drug Development Targeting Cell Death
• Stroke Drug Development Targeting Different Cell Types
• Stroke Drug Development Targeting Other Components

Biologics for Stroke

As research continues to advance and technology evolves, scientists are developing more and more biologics for the treatment of stroke. Based on our professional team and advanced technology platform, we provide comprehensive services for the development of different biologics in areas including but not limited to the development of stem cell therapies, development of gut microbiota therapies, development of therapeutic antibody therapies, development of exosome therapies, and development of UCHL1-based therapies.

• Development of Stem Cell Therapy for Stroke
• Stroke Drug Development Targeting Gut Microbiota
• Development of Therapeutic Antibodies for Stroke
• Development of Exosome-Based Stroke Therapy
• Development of UCHL1-Based Stroke Therapy

Preclinical Drug Study Platform

An integrated and advanced preclinical drug study platform is a fundamental requirement to ensure the science and quality of our research services. Therefore, our scientists are always up to date and proactive in learning the latest knowledge and technology. We also keep our equipment and facilities up to date to meet the needs of different studies. In addition, we have different technical teams in different research areas to ensure the professionalism and science of our team.

• Drug Screening Platform Services
  Small Molecules Library for Stroke Drug Discovery
• Drug Efficacy Testing
  Behavioral Testing Services
  Biomarker Measurement Services for Stroke
  Quantitative Pharmacodynamic Analysis Services for Stroke
• Pharmacokinetic Testing
• Safety Evaluation Testing
• Pharmaceutic Preparation Services

Ace Neuroscience has extensive research experience in the field of stroke drug development and our services have been validated by many parties. Once the project starts, our scientists will be in contact with you at any time to improve or optimize the project details according to your needs. If you would like to learn more about our services, please feel free to contact us.